Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
3450M
Market Cap:
$151.12B
Avg Volume:
329471
P/E Ratio:
-0.010
PEG Ratio:
1.400
Split:
On 1/9/2009 rhhby split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Triple Play In Personalized Medicine
Mar 12, 2012 03:20 PM |
QGEN
,
RHHBY
The Best Way To Invest In Biotech Stocks
Jan 26, 2012 03:49 PM |
CELG
,
GILD
,
ILMN
,
MORN
,
NKTR
Our Outlook For Health-Care Stocks
Jan 04, 2012 11:54 PM |
ABT
,
BDX
,
DGX
,
GILD
,
MDT
,
RHHBY
These International Stocks Are Too Cheap To Ignore
Oct 12, 2011 11:06 AM |
AAUK
,
CEPH
,
HMC
,
MDCO
,
MT
,
MYL
Our Outlook For Health-Care Stocks
Oct 01, 2011 12:05 PM |
ABT
,
ESRX
,
MDT
,
MHS
,
RHHBY
,
ROG
More Articles on RHHBY..
Market News
More News on RHHBY..
Press Releases
Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
May 21, 2012 07:00 AM |
RHHBY
ARUP Laboratories celebrates new state-of-the-art diagnostic technology with the VENTANA BenchMark Special Stains system
May 17, 2012 07:00 AM |
RHHBY
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
May 16, 2012 01:16 AM |
RHHBY
More Press Releases on RHHBY..
SEC Filings
More SEC Filings on RHHBY..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
RHHBY
Compare to S&P
YTD
2.94 %
-2.96 %
4 Weeks
1.88 %
2.82 %
12 Weeks
-2.25 %
-3.53 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-0.01 %
EPS Growth in Last Year:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##